Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

2.64
Delayed Data
As of 12:19pm ET
 -0.05 / -1.86%
Today’s Change
2.31
Today|||52-Week Range
8.12
-55.18%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close2.69
Today’s open2.70
Day’s range2.62 - 2.73
Volume231,660
Average volume (3 months)1,110,011
Market cap$102.0M
Dividend yield--
Data as of 12:19pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-91.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...-0.07-1.34%
BLPHBellerophon Therapeu...+0.14+1.75%
REPHRecro Pharma Inc+1.10+8.50%
ARQLArQule Inc-0.01-0.63%
Data as of 12:19pm ET, 07/02/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$24.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers